Home › Chronic Lymphocytic Leukemia › Indiana › Hammond
Chronic Lymphocytic Leukemia clinical trials in Hammond, IN
3 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Hammond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Ingalls Memorial Hospital, Harvey · 8 mi away
- Advocate South Suburban Hospital, Hazel Crest · 10 mi away
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Ingalls Memorial Hospital, Harvey · 8 mi away
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RecruitingPhase 3
- Northwest Cancer Center - Dyer Clinic /ID# 268478, Dyer · 6 mi away
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Cincinnati, OH14 studies
- Chicago, IL14 studies
Other studies in Hammond
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer9 studies
- Heart Failure8 studies
- Colorectal Cancer5 studies
- Ovarian Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer4 studies
- High Blood Pressure4 studies
- Macular Degeneration4 studies
- COPD3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.